Reinhard Krickl

Reinhard Krickl has held various roles in the medical and technology industries since 1998. From 1998 to 2000, they were a Research Assistant at the Institute of Flexible Automation, Vienna University of Technology. Reinhard then joined Medtronic, where they held several roles from 2000 to 2017, including Business Unit Manager Medtronic RDN Germany, Sales Force Excellence Project Leader, Marketing Manager Medtronic DBS Europe & Central Asia, Product Manager Medtronic DBS Europe & Central Asia, Sales and Marketing Manager Movement Disorders Medtronic Austria, and Sales Rep Medtronic Austria.

In 2017, Krickl became Chairman Of The Board and Non Executive Director at Synergia Medical. Reinhard also became CEO & President of Phagenesis Inc. the same year. In 2019, they became an Advisor at Hadean Ventures, and in 2020 they became Non Executive Director at Nisonic. Most recently, in 2021, Krickl became Non Executive Director & Chairperson at Axem Neurotechnology and a Board Member of the Austrian Seedfinancing Program (Bewertungsgremium) at Austria Wirtschaftsservice.

Reinhard Krickl has an extensive education history. Reinhard obtained a Master of Science in Electrical and Electronics Engineering from Technische Universität Wien between 1990 and 1997. In 2008, they completed an International Marketing program at The Wharton School. Later that year, they obtained a Master of Business Administration (MBA) from IMD. In 2019, they completed the International Directors Programme at INSEAD Executive Education and obtained a certification in Corporate Governance.